Product Name: CompoZr® Knockout ZFN KitNM-001128918
Product Type: Chemical
CAS NO: 297730-17-7Medchemexpress
NCBI accession no.: NM_001128918
Shipped in: dry ice
Storage temp.: −70°C
Biochem/physiol Actions:
The ZFN (zinc finger nuclease) provided in this kit targets the MARK3 (microtubule affinity regulating kinase 3) gene. The MARK3 protein is activated by phosphorylation and is responsible for the phosphorylation of other proteins. Changes in the expression of MARK3 are associated with carcinogenesis.
General description: CompoZr Knockout ZFNs create targeted double strand breaks at a gene specific target locus. Through the cellular process of Non-Homologous End Joining, this double strand break can result in modification of the DNA sequence and therefore create a functional knockout of the targeted gene. To provide the best chance of creating a functional gene knockout, CompoZr Knockout ZFNs are targeted to the first 2/3 of the coding region for the gene of interest.
Legal Information: All Zinc Finger Nucleases are sold under license from Sangamo Biosciences. For a copy of the Label License provided with purchase of CompoZr ZFNs, please visit the ZFN Label License page.
Legal Information: CompoZr is a registered trademark of Sigma-Aldrich Co. LLC
Physical form: CompoZr Knockout ZFNs are provided as 10 aliquots of mRNA encoding for the ZFNs along with plasmid DNA for both ZFN pairs. Also included in the kit are custom-designed primers, that allow for determination of the rate of mutation and for screening of individual clones that have the desired mutational event, and positive control DNA that has been modified using the CompoZr Knockout ZFN.
RIDADR： NONH for all modes of transport
Storage Temp.:−70°C
UNSPSC: 12352200